Brokers bullish on Jindal Saw, UTI Bank, Infosys

Published on Tue, Oct 17, 2006 at 08:51 |  Source : Moneycontrol.com

Updated at Tue, Oct 17, 2006 at 08:55  

4938 Investors following EID Parry. Share this News with them.
0
0
Share on Tumblr

Prabhudas Lilladher has kept buy rating on Jindal Saw; with a target of Rs 550

IL&FS Investsmart has kept buy rating on UTI Bank

Angel Broking has kept hold rating on UTI Bank; with a target of Rs 455

Angel Broking has kept buy rating on Infosys; with a target of Rs 2400

DSP Merrill Lynch has kept buy rating on Zee; with a target of Rs 325

CLSA has kept buy rating on Crompton Greaves

CLSA has kept buy rating on Zee; with a target of Rs 342

Karvy has kept buy rating on EID Parry; with a target of Rs 223

Karvy has maintained outperformer rating on Bajaj Hindustan; with a target of Rs 374

Karvy has kept buy rating on Balrampur Chini Mills; with a target of Rs 133


House

Stocks

Views

Prabhudas Lilladher

Jindal Saw

Buy; with a target of Rs 550

IL&FS Investsmart

UTI Bank

Buy

Angel Broking

UTI Bank

 

 

Infosys

Hold; with a target of Rs 455

 

Buy; with a target of Rs 2400

DSP Merrill Lynch

Zee

Buy; with a target of Rs 325

CLSA

Crompton Greaves

 

Zee

Buy

 

Buy; with a target of Rs 342

Karvy

EID Parry

 

 

Bajaj Hindustan

 

 

Balrampur Chini Mills

Buy; with a target of Rs 223

 

Outperformer; with a target of Rs 374

 

Buy; with a target of Rs 133

  

More on Moneycontrol

Trending News

Business News

How to Root and install Custom Recovery on any Android phone
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com